Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insmed

104.17
-0.4200-0.40%
Post-market: 106.252.08+2.00%19:08 EDT
Volume:2.00M
Turnover:207.70M
Market Cap:19.76B
PE:-17.70
High:105.35
Open:104.73
Low:102.50
Close:104.59
Loading ...

Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), InspireMD (NSPR)

TIPRANKS
·
21 Feb

Insmed Price Target Maintained With a $90.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Feb

Insmed's Q4 Loss Wider Than Expected, Sales In Line With Estimates

Zacks
·
21 Feb

Insmed Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
21 Feb

Insmed (INSM) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
21 Feb

Insmed Inc (INSM) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

GuruFocus.com
·
21 Feb

Insmed’s Strong 2024 Growth and Promising Pipeline

TIPRANKS
·
21 Feb

Stock Track | Insmed Plummets 5.11% in Pre-Market as Wider Q4 Loss Disappoints

Stock Track
·
20 Feb

Insmed Inc - Reiterates 2025 Global Arikayce Revenue Guidance of $405 Mln-$425 Mln

THOMSON REUTERS
·
20 Feb

Insmed's Q4 Loss Widens, Revenue Rises

MT Newswires Live
·
20 Feb

Earnings Flash (INSM) Insmed Posts Q4 Net Revenue $104.4M, vs. FactSet Est of $102.1M

MT Newswires Live
·
20 Feb

Earnings Flash (INSM) Insmed Posts Q4 Net Loss $-1.32 a Share, vs. FactSet Est of $-1.17 Loss

MT Newswires Live
·
20 Feb

Insmed Continues To Anticipate Full-year 2025 Global Arikayce Revenues In The Range Of $405M-$425M, Representing Between 11% And 17% Year-over-year Growth Compared To 2024

Benzinga
·
20 Feb

Insmed Q4 2024 GAAP EPS $(1.32) Misses $(1.17) Estimate, Sales $104.44M Beat $101.79M Estimate

Benzinga
·
20 Feb

BRIEF-Insmed Q4 Revenue USD 104.4 Million Vs. IBES Estimate USD 102.8 Million

Reuters
·
20 Feb

Insmed Q4 Revenue USD 104.4 Million VS. Ibes Estimate USD 102.8 Million

THOMSON REUTERS
·
20 Feb

Insmed Outlook FY Revenue USD 405-425 Million

THOMSON REUTERS
·
20 Feb

Insmed Q4 Net Income USD -235.5 Million VS. Ibes Estimate USD -202.7 Million

THOMSON REUTERS
·
20 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Feb

Cantor Fitzgerald biotech analyst holds an analyst/industry conference call

TIPRANKS
·
20 Feb